TRIB Trinity Biotech PLC ADRs of Class A shares

Trinity Biotech PLC develops, manufactures and markets clinical diagnostic products. Its products are used for detecting autoimmune, sexually transmitted diseases, diabetes and disorders of the liver. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$2.38  0.00 (0.00%)
As of 09/16/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  Ireland
Country of incorporation:  Ireland
IPO date:  02/11/2013
Outstanding shares:  20,901,703
Average volume:  192,179
Market cap:   $49,746,053
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    896438306
ISIN:        US8964383066
Valuation   (See tab for details)
PE ratio:   -26.46
PB ratio:   7.04
PS ratio:   0.43
Return on equity:   379.03%
Net income %:   -1.62%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy